• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Novo Nordisk

Obesity
Marketing

Novo conducts weight stigma conversation at NYC commuter hub

Research into how obesity hits differently depending on factors such as culture, gender and generation informed a Novo exhibit in New York.
Nick Paul Taylor Jan 8, 2026 7:30am
Wegovy pill oral wegovy obesity semaglutide

Novo rings in new year with US launch of Wegovy pill

Jan 5, 2026 10:45am
A paved road that reads 2025 that fades into the sunset

The stories that captivated our audience in 2025

Dec 23, 2025 10:15am
Novo Nordisk

Novo snags FDA nod for oral obesity med with Wegovy in a pill

Dec 22, 2025 6:59pm
FDA

Novo gets warning letter at site formerly owned by Catalent

Dec 16, 2025 10:14am
one white and yellow capsule farther ahead than four other same-colored blue capsules

Novo's oral semaglutide is PCPs' most-anticipated obesity med

Dec 15, 2025 3:46pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings